CU20200086A7 - Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes - Google Patents

Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes

Info

Publication number
CU20200086A7
CU20200086A7 CU2020000086A CU20200086A CU20200086A7 CU 20200086 A7 CU20200086 A7 CU 20200086A7 CU 2020000086 A CU2020000086 A CU 2020000086A CU 20200086 A CU20200086 A CU 20200086A CU 20200086 A7 CU20200086 A7 CU 20200086A7
Authority
CU
Cuba
Prior art keywords
drug
activity against
antimicrobial activity
resistant pathogens
against multi
Prior art date
Application number
CU2020000086A
Other languages
English (en)
Inventor
Perez Hilda Elisa Garay
Vivian Montero-Alejo
Rolando Perdomo-Morales
González Amanda Vázquez
Original Assignee
Centro De Investig Y Desarrollo De Medicamentos Cidem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y Desarrollo De Medicamentos Cidem filed Critical Centro De Investig Y Desarrollo De Medicamentos Cidem
Priority to CU2020000086A priority Critical patent/CU20200086A7/es
Priority to CN202180071094.XA priority patent/CN116406282A/zh
Priority to JP2023523524A priority patent/JP2024508205A/ja
Priority to PCT/CU2021/050011 priority patent/WO2022105948A2/es
Priority to MX2023005925A priority patent/MX2023005925A/es
Priority to CA3199519A priority patent/CA3199519A1/en
Priority to EP21865361.6A priority patent/EP4249500A2/en
Publication of CU20200086A7 publication Critical patent/CU20200086A7/es
Priority to CONC2023/0007878A priority patent/CO2023007878A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>La presente invención describe compuestos peptídicos sintéticos que combaten microorganismos patógenos de naturaleza bacteriana, y que presentan como microorganismos multirresistentes a antibióticos convencionales. Además, describe terapias de combinación que contienen dichos péptidos. Se describen composiciones farmacéuticas que comprenden a los compuestos peptídicos y sus combinaciones.</p>
CU2020000086A 2020-11-19 2020-11-19 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes CU20200086A7 (es)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CU2020000086A CU20200086A7 (es) 2020-11-19 2020-11-19 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes
CN202180071094.XA CN116406282A (zh) 2020-11-19 2021-11-18 具有针对多药耐药性病原体的抗微生物活性的肽实体
JP2023523524A JP2024508205A (ja) 2020-11-19 2021-11-18 多剤耐性病原体に対する抗菌活性を有するペプチド実体
PCT/CU2021/050011 WO2022105948A2 (es) 2020-11-19 2021-11-18 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes
MX2023005925A MX2023005925A (es) 2020-11-19 2021-11-18 Entidades peptidicas con actividad antimicrobiana frente a patogenos multi-drogoresistentes.
CA3199519A CA3199519A1 (en) 2020-11-19 2021-11-18 Peptide entities with antimicrobial activity against multi-drug resistant pathogens
EP21865361.6A EP4249500A2 (en) 2020-11-19 2021-11-18 Peptide entities with antimicrobial activity against multi-drug resistant pathogens
CONC2023/0007878A CO2023007878A2 (es) 2020-11-19 2023-06-15 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2020000086A CU20200086A7 (es) 2020-11-19 2020-11-19 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes

Publications (1)

Publication Number Publication Date
CU20200086A7 true CU20200086A7 (es) 2022-06-06

Family

ID=80684162

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2020000086A CU20200086A7 (es) 2020-11-19 2020-11-19 Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes

Country Status (8)

Country Link
EP (1) EP4249500A2 (es)
JP (1) JP2024508205A (es)
CN (1) CN116406282A (es)
CA (1) CA3199519A1 (es)
CO (1) CO2023007878A2 (es)
CU (1) CU20200086A7 (es)
MX (1) MX2023005925A (es)
WO (1) WO2022105948A2 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0846128B1 (en) * 1995-08-23 2008-10-29 University Of British Columbia Antimicrobial cationic peptides and methods of screening for the same
CU24073B1 (es) 2011-12-27 2015-01-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem COMPOSICIÓN A PARTIR DE EXTRACTO DE HEMOCITOS DE LANGOSTA PARA LA DETECCIÓN DE LIPOPOLISACÁRIDOS, PEPTIDOGLICANOS Y 1,3-ß-D-GLUCANOS
US20200165309A1 (en) * 2017-05-11 2020-05-28 Los Angeles Biomedical Research Institute at Flarbor-UCLA Medical Center Antimicrobial peptides with alpha-core helices

Also Published As

Publication number Publication date
WO2022105948A2 (es) 2022-05-27
JP2024508205A (ja) 2024-02-26
CO2023007878A2 (es) 2023-07-21
WO2022105948A3 (es) 2022-10-20
CN116406282A (zh) 2023-07-07
EP4249500A2 (en) 2023-09-27
CA3199519A1 (en) 2022-05-27
MX2023005925A (es) 2023-05-29

Similar Documents

Publication Publication Date Title
BR112017028413A2 (pt) peptídeos antimicrobianos estabilizados
CO2018010459A2 (es) Composiciones que comprenden cepas bacterianas
EA202192738A1 (ru) Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos
CL2019003892A1 (es) Nuevos derivados de azaquinolina.
CO2018011701A2 (es) Formulaciones de antibióticos glicopeptídicos estabilizados
CL2018003265A1 (es) Modulares del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos.
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
BR112019024264A2 (pt) Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer
BR112018005114A2 (pt) um novo polipeptídeo de endolisina
BR112015029367A8 (pt) combinação compreendendo oxazolidinonaquinolonas, seu uso, composição farmacêutica, e kit de partes
CL2019003078A1 (es) Nuevos derivados de pirazol bicíclicos.
EA201892822A1 (ru) Новые антибактериальные соединения
EP3574900A8 (en) New applications of rifamycin-nitroimidazole coupling molecules
EP3795169A4 (en) RECOMBINANT PROTEIN DERIVED FROM A BACTERIOPHAGE WITH ANTIMICROBIAL ACTIVITY AGAINST PATHOGENIC GRAM-NEGATIVE BACTERIA
AR119025A1 (es) Composición que comprende un bacillus formador de biopelícula
WO2020102901A8 (en) Synthetic antibacterial compounds and uses thereof
CO2021000147A2 (es) Composición agrícola
CU20200086A7 (es) Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes
BR112013008037A2 (pt) compostos multivalentes como tratamento antibiótico
MX2021014310A (es) Formulaciones de terlipressina.
BR112021023169A2 (pt) Métodos e composições para fermentação bacteriana anaeróbica
EP3821903A4 (en) USING THE RECOMBINANT ANTIBACTERIAL ENZYME LYSSAP26 TO EFFECTIVELY KILL PATHOGENIC BACTERIA
BR112019003861A2 (pt) compostos contendo monoterpenoides / fenilpropanóides e métodos de sua fabricação e uso como tratamentos de sementes
BR112022012368A2 (pt) Composto, e, composição farmacêutica para o tratamento de doenças associadas a diacilglicerol aciltransferase 2
BR112021022902A2 (pt) Métodos e composições que compreendem variantes de proteína a staphylococcus (spa)